MCF Advisors’s GeneDx Holdings WGS Stock Holding History

MCF Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-198	Closed	-$25.8K	–	1404
2025 Q4	$25.8K	Sell	198 -70	-26%	-$9.61K	﹤0.01%	640
2025 Q3	$28.9K	Buy	268 +10	+4%	+$1.09K	﹤0.01%	507
2025 Q2	$23.8K	Sell	258 -221	-46%	-$17.3K	﹤0.01%	522
2025 Q1	$42.4K	Buy	479 +128	+36%	+$11.1K	﹤0.01%	417
2024 Q4	$27K	Buy	351 +182	+108%	+$12.7K	﹤0.01%	495
2024 Q3	$7.17K	Buy	+169	New	+$5.71K	﹤0.01%	698

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

MCF Advisors's WGS Position: Q1 2026 in Review

MCF Advisors sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 198 shares — an estimated $25.8K sold.

MCF Advisors first reported a position in WGS in Q3 2024 and held it in 6 quarters. The position peaked at $42.4K in Q1 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

MCF Advisors reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
MCF Advisors sold 198 GeneDx Holdings shares in Q1 2026, an estimated $25.8K.
MCF Advisors first reported a position in GeneDx Holdings in Q3 2024 and held it in 6 quarters.
MCF Advisors's GeneDx Holdings position peaked at $42.4K in Q1 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.